GLYC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

GlycoMimetics (GLYC) Earnings Date & Reports

GlycoMimetics Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

GLYC is expected to report earnings to rise 37.50% to -10 cents per share on November 29

GlycoMimetics GLYC Stock Earnings Reports

Q3'24

Est.

$-0.11

Q4'24

Beat

by $0.01

Q2'24

Est.

$-0.16

Q1'24

Missed

by $0.01

Q4'23

Beat

by $0.01

The last earnings report on February 27 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 46.58K shares outstanding, the current market capitalization sits at 14.70M.

View a ticker or compare two or three

Compare

GLYC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GLYC
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of drugs to treat inflammatory diseases and cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9708 Medical Center Drive

Phone

+1 240 243-1201

Employees

Web

https://www.glycomimetics.com